Abstract 1906: UNO-A001 (A001), a clinical candidate CD38 x CD3 bispecific with a novel structure, potently kills multiple myeloma cells <i>in vitro</i> and is highly effective <i>in vivo</i>

Authors: Mark Anderson, Yan Ling, Mark L. Chiu, Peter Cheung

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-1906

Source: Full article


Abstract

Abstract